These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Pharmacological Properties and Therapeutic Potential of Naringenin: A Citrus Flavonoid of Pharmaceutical Promise. Rani N; Bharti S; Krishnamurthy B; Bhatia J; Sharma C; Kamal MA; Ojha S; Arya DS Curr Pharm Des; 2016; 22(28):4341-59. PubMed ID: 27238365 [TBL] [Abstract][Full Text] [Related]
4. Naringenin Inhibits Superoxide Anion-Induced Inflammatory Pain: Role of Oxidative Stress, Cytokines, Nrf-2 and the NO-cGMP-PKG-KATP Channel Signaling Pathway. Manchope MF; Calixto-Campos C; Coelho-Silva L; Zarpelon AC; Pinho-Ribeiro FA; Georgetti SR; Baracat MM; Casagrande R; Verri WA PLoS One; 2016; 11(4):e0153015. PubMed ID: 27045367 [TBL] [Abstract][Full Text] [Related]
5. Dietary phytophenols curcumin, naringenin and apigenin reduce infection-induced inflammatory and contractile pathways in human placenta, foetal membranes and myometrium. Lim R; Barker G; Wall CA; Lappas M Mol Hum Reprod; 2013 Jul; 19(7):451-62. PubMed ID: 23475986 [TBL] [Abstract][Full Text] [Related]
6. Naringenin: A prospective therapeutic agent for Alzheimer's and Parkinson's disease. Goyal A; Verma A; Dubey N; Raghav J; Agrawal A J Food Biochem; 2022 Dec; 46(12):e14415. PubMed ID: 36106706 [TBL] [Abstract][Full Text] [Related]
7. Implication of cyclic nucleotide phosphodiesterase inhibition in the vasorelaxant activity of the citrus-fruits flavonoid (+/-)-naringenin. Orallo F; Camiña M; Alvarez E; Basaran H; Lugnier C Planta Med; 2005 Feb; 71(2):99-107. PubMed ID: 15729616 [TBL] [Abstract][Full Text] [Related]
8. Effect of citrus flavonoids, naringin and naringenin, on metabolic syndrome and their mechanisms of action. Alam MA; Subhan N; Rahman MM; Uddin SJ; Reza HM; Sarker SD Adv Nutr; 2014 Jul; 5(4):404-17. PubMed ID: 25022990 [TBL] [Abstract][Full Text] [Related]
9. The citrus flavonoid naringenin confers protection in a murine endotoxaemia model through AMPK-ATF3-dependent negative regulation of the TLR4 signalling pathway. Liu X; Wang N; Fan S; Zheng X; Yang Y; Zhu Y; Lu Y; Chen Q; Zhou H; Zheng J Sci Rep; 2016 Dec; 6():39735. PubMed ID: 28004841 [TBL] [Abstract][Full Text] [Related]
10. Naringenin and its Nano-formulations for Fatty Liver: Cellular Modes of Action and Clinical Perspective. Zobeiri M; Belwal T; Parvizi F; Naseri R; Farzaei MH; Nabavi SF; Sureda A; Nabavi SM Curr Pharm Biotechnol; 2018; 19(3):196-205. PubMed ID: 29766801 [TBL] [Abstract][Full Text] [Related]
11. Naringenin ameliorates learning and memory impairment following systemic lipopolysaccharide challenge in the rat. Khajevand-Khazaei MR; Ziaee P; Motevalizadeh SA; Rohani M; Afshin-Majd S; Baluchnejadmojarad T; Roghani M Eur J Pharmacol; 2018 May; 826():114-122. PubMed ID: 29518393 [TBL] [Abstract][Full Text] [Related]
12. Naringenin more effectively inhibits inducible nitric oxide synthase and cyclooxygenase-2 expression in macrophages than in microglia. Chao CL; Weng CS; Chang NC; Lin JS; Kao ST; Ho FM Nutr Res; 2010 Dec; 30(12):858-64. PubMed ID: 21147369 [TBL] [Abstract][Full Text] [Related]
13. Antinociceptive and anti-inflammatory effect of Naringenin in different nociceptive and inflammatory mice models. Xue N; Wu X; Wu L; Li L; Wang F Life Sci; 2019 Jan; 217():148-154. PubMed ID: 30414428 [TBL] [Abstract][Full Text] [Related]
14. Naringenin: A flavanone with anti-inflammatory and anti-infective properties. Cai J; Wen H; Zhou H; Zhang D; Lan D; Liu S; Li C; Dai X; Song T; Wang X; He Y; He Z; Tan J; Zhang J Biomed Pharmacother; 2023 Aug; 164():114990. PubMed ID: 37315435 [TBL] [Abstract][Full Text] [Related]
15. A Comprehensive Systematic Review of the Effects of Naringenin, a Citrus-Derived Flavonoid, on Risk Factors for Nonalcoholic Fatty Liver Disease. Naeini F; Namkhah Z; Ostadrahimi A; Tutunchi H; Hosseinzadeh-Attar MJ Adv Nutr; 2021 Mar; 12(2):413-428. PubMed ID: 32879962 [TBL] [Abstract][Full Text] [Related]
16. Beneficial effects of naringenin in liver diseases: Molecular mechanisms. Hernández-Aquino E; Muriel P World J Gastroenterol; 2018 Apr; 24(16):1679-1707. PubMed ID: 29713125 [TBL] [Abstract][Full Text] [Related]
19. Naringenin attenuates the release of pro-inflammatory mediators from lipopolysaccharide-stimulated BV2 microglia by inactivating nuclear factor-κB and inhibiting mitogen-activated protein kinases. Park HY; Kim GY; Choi YH Int J Mol Med; 2012 Jul; 30(1):204-10. PubMed ID: 22552813 [TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetic, pharmacodynamic and formulations aspects of Naringenin: An update. Joshi R; Kulkarni YA; Wairkar S Life Sci; 2018 Dec; 215():43-56. PubMed ID: 30391464 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]